Kaya Holdings (KAYS) EBT Margin (2014 - 2025)
Kaya Holdings (KAYS) recorded quarterly EBT Margin of 158865.85% in Q3 2025, down 514.74% quarter-over-quarter from 25842.69% in Q2 2025, and down 7894275.0% on a YoY basis from N/an in Q3 2024.
Kaya Holdings (KAYS) EBT Margin (2014 - 2025) Analysis & Trends
Kaya Holdings' EBT Margin history runs 12 years deep, the most recent figure standing at 158865.85% for Q3 2025.
- In Q3 2025, EBT Margin fell 7894275.0% year-over-year to 158865.85%; the TTM figure through Sep 2025 stood at 903816.01% (up 90837566.0% YoY), while the FY2024 annual figure was 28877.36%, down 2964148.0% from the prior year.
- EBT Margin was 158865.85% for Q3 2025 at Kaya Holdings, down from 25842.69% in the prior quarter.
- In the past five years, EBT Margin ranged from a high of 3803.11% in Q2 2021 to a low of 158865.85% in Q3 2025.
- Historically, EBT Margin has averaged 16159.75% across 5 years, with a median of 932.15% in 2022.
- The sharpest annual moves came in 2023 and 2024: EBT Margin surged 784593 bps in 2023, then sank 8348347 bps in 2024.
- A 5-year view of EBT Margin shows it stood at 1327.65% in 2021, then climbed by 2 bps to 1359.78% in 2022, then tumbled by 86 bps to 189.55% in 2023, then plunged by 2232 bps to 4041.11% in 2024, then sank by 3831 bps to 158865.85% in 2025.
- The last three EBT Margin figures came in at 158865.85% (Q3 2025), 25842.69% (Q2 2025), and 23770.67% (Q1 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.34 Bn | 34.60 Bn | 1.97 Bn | 10.97% |
| 2 | Zoetis | 33.27 Bn | 31.33 Bn | 1.62 Bn | 33.51% |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn | 40.73% |
| 4 | Aurora Cannabis | 17.11 Bn | 17.03 Bn | 33.43 Mn | 25.87% |
| 5 | Neurocrine Biosciences | 16.37 Bn | 15.05 Bn | 800.70 Mn | 30.30% |
| 6 | Elanco Animal Health | 11.78 Bn | 11.35 Bn | 785.00 Mn | 6.35% |
| 7 | Alkermes | 7.05 Bn | 6.54 Bn | -116.06 Mn | -156.77% |
| 8 | Lantheus Holdings | 6.49 Bn | 5.99 Bn | 230.92 Mn | 41.45% |
| 9 | Hims & Hers Health | 6.19 Bn | 5.44 Bn | 396.79 Mn | -16.70% |
| 10 | Kaya Holdings | - | - | 5,370.00 | -158,865.85% |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | -158,865.85% |
| Jun 30, 2025 | -25,842.69% |
| Mar 31, 2025 | -23,770.67% |
| Dec 31, 2024 | -4,041.11% |
| Sep 30, 2024 | -79,923.10% |
| Mar 31, 2024 | -3,724.18% |
| Dec 31, 2023 | 189.55% |
| Sep 30, 2023 | 3,560.37% |
| Jun 30, 2023 | -1,282.37% |
| Mar 31, 2023 | 85.82% |
| Dec 31, 2022 | 1,359.78% |
| Sep 30, 2022 | -4,285.56% |
| Jun 30, 2022 | 1,600.84% |
| Mar 31, 2022 | -581.93% |
| Dec 31, 2021 | 1,327.65% |
| Sep 30, 2021 | 1,837.78% |
| Jun 30, 2021 | 3,803.11% |
| Mar 31, 2021 | -2,322.95% |
| Dec 31, 2020 | 1,275.30% |
| Sep 30, 2020 | -4,877.98% |